ENvue Medical Inc
FEED
6 hedge funds and large institutions have $2.2M invested in ENvue Medical Inc in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
16% more capital invested
Capital invested by funds: $1.91M → $2.2M (+$297K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$57.5K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$32.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
FEED Hedge Fund Activity: Q1 2019 in Review
6 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2019, worth a combined $2.2M — up 16% from $1.91M a quarter earlier.
Fund positioning in FEED was balanced in Q1 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $57.5K. The largest seller was UBS Group, exiting entirely with an estimated $16K sold.
- 6 institutional investors held ENvue Medical Inc (FEED) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $2.2M of ENvue Medical Inc stock for Q1 2019, up 16% quarter-over-quarter.
- 1 fund opened new ENvue Medical Inc positions in Q1 2019 and 1 closed out, a net change of 0 holders.
- The largest ENvue Medical Inc buyer in Q1 2019 was Citadel Advisors, an estimated $57.5K added.
- The largest ENvue Medical Inc seller in Q1 2019 was UBS Group, an estimated $16K sold.
Based on aggregated 13F filings for Q1 2019.